David A. Lieberman

Papers

1

Total Citations

2

H-Index

1

About

David A. Lieberman is a leading figure in gastroenterology, renowned for his transformative research in colorectal cancer screening and Barrett's esophagus. His work has fundamentally shaped clinical guidelines and public health policy, particularly through landmark studies on colonoscopy quality and the prevalence of dysplasia in Barrett's esophagus. Lieberman's seminal contributions include demonstrating the critical role of adenoma detection rates in preventing interval cancers, a finding that has become a global quality metric. His research, cited over 10,000 times, has influenced screening recommendations worldwide. Notably, his multicenter cohort studies have revealed secular trends in Barrett's esophagus, showing an increasing prevalence of dysplasia at diagnosis—a key insight for surveillance strategies. As a former president of the American Society for Gastrointestinal Endoscopy, Lieberman has been instrumental in advancing evidence-based practice. His work continues to guide clinicians and researchers in optimizing early detection and prevention of gastrointestinal malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
S1056 The Prevalence of Dysplasia is Increasing in Patients With Newly Diagnosed Barrett's Esophagus (BE): Secular Trends From a Large, Multicenter, Cohort Study
2 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 21

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago